About Amber Compounding Pharmacy
Amber Compounding Pharmacy is a Healthcare company based in Singapore (Singapore) founded in 2008, and was acquired by Fagron in December 2025. Customized medicines are provided by Amber Compounding Pharmacy. It operates on a Professional Services and Direct-to-Consumer (D2C) model. Amber Compounding Pharmacy offers products and services including Dermatology Compounding, Nutritional Compounding, Veterinary Medicines, Pain Management, and Bio-identical Hormones. Its focus areas include Pharmaceuticals and Compounding Pharmacy. Its legal entity is Amber Compounding Pharmacy Pte Ltd.
Company details
Amber Compounding Pharmacy is engaged in creating tailored medications and healthcare solutions. Services are offered across sectors like dermatology, nutritional compounding, veterinary medicines, pain management, and bio-identical hormone therapy. Unique formulations are developed for doctors, naturopaths, veterinarians, and patients. Retail stores are operated in Singapore and Malaysia, ensuring high-quality, evidence-based compounded drugs.
- Headquarters Singapore, Singapore
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website amber-pharmacy.com
- Social LinkedIn
- Acquired by Fagron (Dec 2025)
- Legal Name Amber Compounding Pharmacy Pte Ltd
Products & Services of Amber Compounding Pharmacy
Amber Compounding Pharmacy offers a comprehensive portfolio of products and services, including Dermatology Compounding, Nutritional Compounding, Veterinary Medicines, Pain Management, and Bio-identical Hormones.
Custom drugs are formulated for various skin conditions.
Vitamins and minerals are tailored for specific deficiencies.
Custom formulations are created for animal treatment compliance.
Personalized medications are developed to alleviate chronic pain.
Hormone therapy is customized for improved life quality.
Investors in Amber Compounding Pharmacy
Amber Compounding Pharmacy has secured backing from 1 investor. Prominent investors backing the company include Fagron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug compounding services are provided by Fagron. | 1990 | fagron.com | Saint Paul, United States |
Investor details for Amber Compounding Pharmacy
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Amber Compounding Pharmacy
2 dated milestones of Amber Compounding Pharmacy across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Amber Compounding Pharmacy is founded.
- Exit Acquired by Fagron.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amber Compounding Pharmacy
Amber Compounding Pharmacy was founded in 2008.
Amber Compounding Pharmacy is headquartered in Singapore, Singapore.
Amber Compounding Pharmacy is engaged in creating tailored medications and healthcare solutions. Services are offered across sectors like dermatology, nutritional compounding, veterinary medicines, pain management, and bio-identical hormone therapy. Unique formulations are developed for doctors, naturopaths, veterinarians, and patients. Retail stores are operated in Singapore and Malaysia, ensuring high-quality, evidence-based compounded drugs.
Amber Compounding Pharmacy offers Dermatology Compounding, Nutritional Compounding, Veterinary Medicines, Pain Management, and Bio-identical Hormones.
Amber Compounding Pharmacy has 1 investor. Key investors include Fagron.
Amber Compounding Pharmacy operates through Amber Compounding Pharmacy Pte Ltd.
Yes. Amber Compounding Pharmacy was acquired by Fagron in December 2025.
